Rentiapril
Rentiapril is an orally active angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity[1][2].
Product Specifications
CAS Number
80830-42-8
Product Name Alternative
SA-446
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/rentiapril.html
Purity
99.59
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
SCCC(N1[C@@H](C2=C(C=CC=C2)O)SC[C@H]1C(O)=O)=O
Molecular Formula
C13H15NO4S2
Molecular Weight
313.39
References & Citations
[1]Cozens DD, et al. Reproductive toxicity studies of rentiapril. Arzneimittelforschung. 1987 Feb;37 (2) :164-9.|[2]Ideishi M, et al. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Clin Ther. 1989 Jul-Aug;11 (4) :441-51.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![HOXC4 Mouse Monoclonal Antibody [Clone ID: OTI1A6]](https://cdn.genprice.uk/products/937/68dd18ba061270361e908682/imageurl/cf809671.webp)
